🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Myelodysplastic syndromes (MDS) comprise a heterogeneous group of clonal bo...
Status
Unknown
Location
Chu Grenoble Alpes
Start Date
2020-07-27
Trial ID
NCT04399018
Treatments Being Tested
The current typical pathway for patients with enlarged lymph glands is to u...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07739849
Treatments Being Tested
The purpose of this research study is to determine the genetic changes and ...
Status
Recruiting
Location
Hillman Cancer Center
Start Date
1996-06
Trial ID
NCT00280202
Previous work performed by University of New Mexico Comprehensive Cancer Ce...
Status
Terminated
Location
University of New Mexico Comprehensive Cancer Center
Start Date
2016-07-28
Trial ID
NCT02580981
Treatments Being Tested
There are limited data about the role of regulatory B cells in Behcet Disea...
Status
Completed
Location
Assiut University
Start Date
2018-12-15
Trial ID
NCT04376411
Acute lymphoblastic leukemia is a type of blood cancer that primarily affec...
Status
Not Yet Recruiting
Location
CHU de Nice
Start Date
2026-04-30
Trial ID
NCT07529223
Treatments Being Tested
Colorectal cancers are the third most common cancer in the world. In advanc...
Status
Completed
Location
Istanbul Training and Reseach Hospital
Start Date
2020-08-01
Trial ID
NCT04566848
Treatments Being Tested
T-ALL (T-acute lymphoblastic leukemia) is an aggressive blood cancer, where...
Status
Recruiting
Location
Dr.Sumeet Mirgh
Start Date
2023-08-28
Trial ID
NCT07021677
Treatments Being Tested
Pancreatitis is a common complication especially in patients with gallbladd...
Status
Completed
Location
Istanbul Traininng and Research Hospital
Start Date
2019-06-01
Trial ID
NCT03937323
Treatments Being Tested
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy. It ...
Status
Completed
Location
South Egypt Cancer Institute, Assiut University
Start Date
2022-07-01
Trial ID
NCT06369662